JAK2 and myeloproliferative neoplasm: To investigate the clonal trajectory post-MPN sAML, we performed single cell genomic analysis for three paired patient samples (2 MF; 1 PV) who progressed from a JAK2V617F-mutant MPN to a JAK2-negative sAML as defined by clinical sequencing (Figure S1A).